CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
pantients undergoing pancreaticoduodenectomyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05506748
NCT05506748N/ACompleted
CompareCT.gov

Association Between Preoperative HALP and Immediate Postoperative Outcomes in Patients Undergoing Pancreaticoduodenectomy

Chitwan Medical College·observational·Posted Aug 18, 2022·Updated Aug 18, 2022

In Brief

An observational study evaluating pantients undergoing pancreaticoduodenectomy for Hemoglobins and 6 related conditions. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Multiple inflammation-based prognostic scores have been developed for the prediction of perioperative morbidity and mortality following pancreaticoduodenectomy (PD). Preoperative "Hemoglobin, Albumin, Lymphocytes and Platelets index (HALP)" is one of the promising inflammatory markers that has emerged as a predictor of postoperative survival. To date, no study has been done with preoperative HALP to predict 30days morbidity and mortality. Is there any association between Preoperative HALP (hemoglobin, albumin, lymphocyte, and platelet) and 30 days post operative morbidity and mortality in patients undergoing Pancreaticoduodenectomy?

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemoglobins, Albumins, Platelets, Lymphocytes, Morbidity, Mortality, Whipples Procedure
CountriesNepal
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 18, 2022
Enrollment StartApr 20, 2021
Primary CompletionApr 20, 2022
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 3.9 years ago

Interventions

pantients undergoing pancreaticoduodenectomyother

The study includes all the cases who underwent pancreaticoduodenectomy for carcinoma head of the pancreas, distal cholangiocarcinoma, periampullary and duodenal cancer.